Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Autor:
Inam, Farha, Bergin, Rebecca J., Mizrahi, David, Dunstan, David W., Moore, Melissa, Maxwell-Davis, Natalie, Denehy, Linda, Lynch, Brigid M., Swain, Christopher T. V.
Publikováno v:
Supportive Care in Cancer; Nov2023, Vol. 31 Issue 11, p1-9, 9p
Financial toxicity in female patients with breast cancer: a national cross-sectional study in China.
Publikováno v:
Supportive Care in Cancer; Oct2022, Vol. 30 Issue 10, p8231-8240, 10p
Publikováno v:
Supportive Care in Cancer
Purpose Pneumatic compression devices (PCDs) are used in the home setting as adjunctive treatment for lymphedema after acute treatment in a clinical setting. PCDs range in complexity from simple to technologically advanced. The objective of this pros
Autor:
Yuanyuan Wang, Jorge Arellano, Charles S. Cleeland, Mark S. Walker, Alexander Liede, Roger von Moos, Mariana Chavez-MacGregor, Yi Qian, Jianqing Gao, Arun Balakumaran
Publikováno v:
Supportive Care in Cancer
Purpose Women with breast cancer frequently develop painful bone metastases. This retrospective study was designed to longitudinally characterize patterns of patient-reported symptoms among patients with breast cancer relative to the diagnosis of bon
Publikováno v:
Supportive Care in Cancer
Purpose The aim of this study is to characterize the patterns of medication use by early-stage breast cancer (ESBC) survivors from diagnosis to 1 year post-chemotherapy. Methods A single-center longitudinal study was conducted with ESBC patients diag
Autor:
Jae Hoo Park, In Sil Choi, In Hae Park, Jee Hyun Kim, Ki Hyeong Lee, Hee Jun Kim, Keon Uk Park, Hye Sook Han, Jiyeon Kim, So Young Yoon, Seock-Ah Im, Si Young Kim, Kyung Hae Jung, Moon Hee Lee, Eun Kyung Cho, Young Jin Choi, Joo Han Lim, Do-Youn Oh
Publikováno v:
Supportive Care in Cancer
Purpose Pegylated granulocyte-colony-stimulating factor (G-CSF) is frequently used to prevent febrile neutropenia (FN) in patients undergoing chemotherapy with a high risk of myelosuppression. This phase II/III study was conducted to determine the ad
Autor:
Naoko Minatani, Norihiko Sengoku, Masaru Kuranami, Hiroshi Nishimiya, Mariko Kikuchi, Hiroshi Katoh, Mina Waraya, Yoshimasa Kosaka, Hirokazu Tanino, Takeo Sato, Masahiko Watanabe, Takumo Enomoto
Publikováno v:
Supportive Care in Cancer
Purpose Dexamethasone, plus a 5-HT3 receptor antagonist and an NK-1 receptor antagonist are recommended for controlling the chemotherapy-induced nausea and vomiting (CINV) of highly emetogenic chemotherapy. Several days of dexamethasone are effective